GoodRx, Inc., a leading player in the healthcare technology sector, is headquartered in the United States. Founded in 2011, the company has revolutionised the way consumers access prescription medications by providing a platform that compares prices and offers discounts at local pharmacies. With a focus on transparency and affordability, GoodRx has become a trusted resource for millions of Americans seeking to save on their healthcare costs. The company’s core services include a user-friendly website and mobile app that allow users to find the best prices for medications, access coupons, and explore telehealth options. GoodRx's unique approach to prescription savings has positioned it as a market leader, with notable achievements such as partnerships with major pharmacy chains and a significant user base. As the demand for affordable healthcare solutions continues to grow, GoodRx remains at the forefront of the industry, committed to helping consumers navigate the complexities of prescription costs.
How does GoodRx, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Computer Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
GoodRx, Inc.'s score of 23 is lower than 67% of the industry. This can give you a sense of how well the company is doing compared to its peers.
GoodRx, Inc., headquartered in the US, currently does not have publicly available carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Furthermore, there are no documented reduction targets or climate pledges associated with the company. It is important to note that GoodRx, Inc. is a current subsidiary and may inherit emissions data and climate commitments from its parent or related organizations. However, no specific cascading data from a parent company has been provided. As the company continues to navigate its environmental impact, it remains essential for GoodRx, Inc. to establish clear climate commitments and reduction initiatives in line with industry standards.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
GoodRx, Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.

